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Dystroglycan is a highly glycosylated extracellular matrix receptor with essential 
functions in skeletal muscle and the nervous system. Reduced matrix binding by 
α-dystroglycan (α-DG) due to perturbed glycosylation is a pathological feature of 
several forms of muscular dystrophy. Like-acetylglucosaminyltransferase (LARGE) 
synthesizes the matrix-binding heteropolysaccharide [-glucuronic acid-β1,3-xylose-
α1,3-]n. Using a dual exoglycosidase digestion, we confirm that this polysaccharide is 
present on native α-DG from skeletal muscle. The atomic details of matrix binding were 
revealed by a high-resolution crystal structure of laminin G-like (LG) domains 4-5 of 
laminin α2 bound to a LARGE-synthesized oligosaccharide. A single glucuronic acid-
β1,3-xylose disaccharide repeat straddles a Ca2+ ion in the LG4 domain, with oxygen 
atoms from both sugars replacing Ca2+-bound water molecules. The chelating binding 
mode accounts for the high affinity of this protein-carbohydrate interaction. These 
results reveal a novel mechanism of carbohydrate recognition and provide a structural 
framework for elucidating the mechanisms underlying muscular dystrophy. 
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Dystroglycan is a widely expressed transmembrane glycoprotein that requires complex post-
translational processing to function as an extracellular matrix (ECM) receptor1-3. The protein 
is involved in a variety of physiological and developmental processes, including maintenance 
of skeletal muscle function, as well as formation and function of the central nervous system3-
6. Synthesized as a single polypeptide, dystroglycan is cleaved autoproteolytically to yield a 
cell-surface α-subunit and a transmembrane β-subunit7. The extensively glycosylated 
α-dystroglycan (α-DG) acts as a receptor for laminin G (LG) domain-containing ECM 
proteins that are major constituents of the basement membrane of skeletal muscle and other 
tissues: laminin, agrin, and perlecan8. Abnormalities in the post-translational processing of 
α-DG that disrupt the interaction with the basement membrane result in various congenital 
and limb-girdle muscular dystrophies, referred to collectively as secondary 
dystroglycanopathies9. The ECM-binding modification of α-DG also mediates interactions 
with the LG domains of neurexins10, pikachurin11 and Slit12, thereby contributing to synapse 
formation and axon guidance. Finally, α-DG serves as a cellular receptor for Old World 
arenaviruses, including the highly pathogenic Lassa fever virus, and the requirements for 
virus entry mirror those for LG domain binding13,14. 
 At least 17 gene products, many of which are glycosyltransferases, are involved in 
biosynthesis of the functional α-DG modification15. The modification is initiated by a unique 
O-linked trisaccharide, GalNAc-β1,3-GlcNAc-β1,4-Man-Ser/Thr, which is phosphorylated at 
position 6 of the mannose residue16,17. The GalNAc is linked, via a tandem ribitol-5-
phosphate moiety18, to a heteropolysaccharide that is comprised of alternating glucuronic 
acid (GlcA) and xylose (Xyl) residues and synthesized by the bifunctional like-
acetylglucosaminyltransferase (LARGE)19. LARGE is essential for skeletal muscle function 
in mice20,21 and humans22. The LARGE-synthesized [-GlcA-β1,3-Xyl-α1,3-]n 
heteropolysaccharide has been termed matriglycan for its ability to bind LG domain-
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containing proteins in vitro15,20. However, direct evidence for the presence of matriglycan on 
native α-DG, as expressed in vivo in skeletal muscle, is currently lacking. 
Within basement membranes, the heterotrimeric laminins form cell-associated 
networks that have both mechanical and signaling functions8. Laminin interactions with cell 
surface receptors, including α-DG, are mediated by five tandem LG domains at the 
C-terminus of the laminin α chain8. Each LG domain consists of ~200 residues folded into a 
β-sandwich23. LG domains that bind α-DG contain a Ca2+ ion bound to one rim of the 
β-sandwich, consistent with the strict Ca2+-dependence of the interaction24,25. How the Ca2+ 
site of the LG domain mediates the specific recognition of α-DG is a major unresolved 
question. 
In this study, we developed a novel dual exoglycosidase digestion protocol for 
matriglycan. Using this protocol, we show that native α-DG from skeletal muscle contains 
the unmodified heteropolysaccharide [-GlcA-β1,3-Xyl-α1,3-]n, and that its presence confers 
laminin binding. Crystal structures of laminin α2 LG4-5 with a LARGE-synthesized 
oligosaccharide reveal that the Ca2+ ion in LG4 is chelated by a single GlcA-β1,3-Xyl 
disaccharide. This binding mode, which is unprecedented among animal lectins, is predicted 
to be conserved in other LG domains. Our study thus provides the first atomic-resolution 
insights into the ECM receptor function of dystroglycan. 
 
 
RESULTS 
 
Exoglycosidase digestion of native α-DG 
Direct evidence for the presence of GlcA-Xyl repeats is not available for native or 
recombinant α-DG, and the presence of GlcA or Xyl has only been demonstrated for α-DG 
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produced in LARGE-expressing human embryonic kidney 293 cells19. To confirm that this 
polysaccharide structure is also present in native tissues, we identified two exoglycosidases 
that collectively can hydrolyze glycans on native α-DG: β-glucuronidase (Bgus) from 
T. maritima26, and α-xylosidase (Xylsa) from S. solfataricus27. We first tested these enzymes 
with a chemically defined substrate, the LARGE-synthesized pentasaccharide G5 (Fig. 1). 
Alternating treatment of G5 with the two enzymes removed one sugar at a time from the non-
reducing end, demonstrating that Bgus and Xylsa cleave β-linked GlcA and α-linked Xyl, 
respectively, without measurable endoglycosidase activity. 
 The simultaneous treatment of rabbit skeletal muscle α-DG with Bgus and Xylsa 
dramatically reduced the apparent molecular mass of α-DG, as assessed by SDS-PAGE, and 
abolished reactivity with the matriglycan-specific antibody IIH6, whereas treatment of α-DG 
with either exoglycosidase alone had no such effect (Fig. 2a, Supplementary Results, 
Supplementary Fig. 1). Similar results were obtained with mouse skeletal muscle α-DG: 
wild-type mouse α-DG treated with both Bgus and Xylsa migrated similarly to α-DG from 
Largemyd mice, which have an inactivating mutation in the Large gene21 (Fig 2b), and failed 
to react with matriglycan-specific antibodies IIH6 and VIA41, as well as with laminin (Fig. 
2c). These findings demonstrate that native α-DG in skeletal muscle of rabbit and mouse is 
modified with multiple [-GlcA-β1,3-Xyl-α1,3-] repeats, and that this modification is required 
for the ability of α-DG to bind ligand. 
 
Structure of a GlcA-Xyl oligosaccharide bound to laminin 
A major binding partner for α-DG in skeletal muscle is the LG4-5 region of the laminin α2 
chain28,29, specifically the Ca2+ site in the LG4 domain25. To reveal the structural 
determinants of α-DG binding, we soaked a mixture of LARGE-synthesized hexa- and 
heptasaccharide (G6/7; the only oligosaccharide available at the time) into crystals of laminin 
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α2 LG4-5 with an unobstructed LG4 Ca2+ site. Form C crystals soaked in 250 µM G6/7 
diffracted to a resolution of 1.4 Å (Supplementary Table 1). The difference electron density 
around the LG4 Ca2+ site unambiguously defines a GlcA-Xyl disaccharide (Fig. 3a, 
Supplementary Fig. 2). There is weaker density for the two sugars flanking the Ca2+-bound 
disaccharide, as well as a flat electron density feature situated on a crystallographic dyad that 
we interpreted as the 4-methylumbelliferone (MU) group of G6/7. The Ca2+-bound 
disaccharide accordingly is assigned as GlcA3-Xyl2. We cannot rule out that the Ca2+-bound 
disaccharide is GlcA5-Xyl4, or a superposition of multiple binding modes, but this ambiguity 
does not affect any of our conclusions. All of the glycosidic bonds assume stereochemically 
favorable torsion angles (Supplementary Table 2). Form I crystals soaked in 850 µM G6/7 
diffracted to 2.0 Å resolution (Supplementary Table 1). The four sugars defined by the 
electron density bind in essentially the same way as in form C crystals, but the MU group is 
positioned differently as a result of its stacking against a symmetry mate (Supplementary 
Fig. 3). Thus, the conformation of the MU group appears to be determined largely by the 
crystal lattice, and not by specific interactions with laminin α2 LG4-5. 
 The G6/7 oligosaccharide is bound to LG4 in a shallow depression centered on the 
Ca2+ site, burying 200 Å2 of solvent-accessible protein surface (Fig. 3b). The interaction 
involves almost exclusively a single disaccharide repeat, GlcA3-Xyl2, which coordinates the 
Ca2+ ion identically in both crystal forms (Fig. 3c). The GlcA3 carboxylate group is locked 
into place by two hydrogen bonds with the protein backbone, and one of its oxygen atoms 
coordinates the Ca2+ ion (2.5 Å distance). The ring oxygen atom of GlcA3 is positioned 3.0 Å 
from the Ca2+ ion; this distance is longer than a typical Ca2+-O coordination bond, but likely 
short enough for a favorable contribution to the binding energy. Ca2+ coordination by the 
GlcA ring oxygen atom has been described30. The Xyl2 4-OH group coordinates the Ca2+ ion 
(2.4 Å) and forms a hydrogen bond with the Ca2+ ligand Asp2808. Excluding the long bond 
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to the GlcA ring oxygen atom, the resulting Ca2+ coordination geometry is octahedral, with 
four coordinating atoms provided by the protein and two by the carbohydrate (Fig. 3c). 
Another notable feature is the stacking of Xyl2 against Arg2803, a residue that is essential for 
α-DG binding25. In form C crystals, Xyl2 C5 is in close contact with the side chains of 
Ala2807 and Asp2808 (3.7 and 3.3 Å, respectively), and the GlcA1 2-OH group forms a 
hydrogen bond to the protein backbone (Fig. 3c). In form I crystals, the conformation of the 
GlcA1-MU portion of G6/7 differs from that in form C crystals, resulting in a slight rotation 
of Xyl2 and concomitant disruption of the close contacts of Xyl2 C5 (Supplementary 
Fig. 3). Even in the more relaxed conformation observed in form I crystals, however, a 
hexose in place of Xyl2 would clash with Arg2803 and/or Ala2807. The steric exclusion of 
5-substituted sugars likely explains why laminins do not bind hyaluronic acid, an abundant 
extracellular matrix polysaccharide consisting of GlcA-β1,3-GlcNAc repeats 
(Supplementary Fig. 4). 
 
Laminin affinity for GlcA-Xyl oligosaccharides 
To determine the affinity of laminin α2 LG4-5 for LARGE-synhesized oligosaccharides, we 
used NMR spectroscopy. Because the G6/7 mixture used in the crystallographic experiments 
was not suitable for NMR experiments, we studied the pentasaccharide G5 (Fig. 4a). The 
peaks of three anomeric protons of G5 were resolved in the presence of LG4-5, and their 
intensities were found to decrease with increasing LG4-5 protein concentration (Fig. 4b). In 
agreement with an earlier study of α-DG binding to LG4-5 protein25, the interaction with G5 
was observed only in the presence of Ca2+ (Fig. 4c). A dissociation constant of 0.23 µM was 
obtained by fitting the intensity changes of the Xyl4 peak, which was most sensitive to 
titration with LG4-5 (Fig. 4d). Interestingly, the peaks of the aromatic MU protons remained 
intense and sharp even in the presence of saturating LG4-5 concentrations, indicating that the 
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MU group is mobile and does not interact with the protein (Supplementary Fig. 5). We 
therefore believe that the MU group makes only a negligible contribution to the measured 
affinity for G5. 
 Similar experiments with the trisaccharide GlcA-Xyl-GlcA-MU (G3) and the 
disaccharide GlcA-Xyl-MU (X2) gave dissociation constants of 3.7 and 47 µM, respectively 
(Supplementary Figs. 6 and 7). The comparatively weak binding of X2 is most likely the 
result of steric hindrance by the MU group. The 16-fold stronger binding of G5 compared 
with G3 can be explained partially by the statistical effect of multiple binding sites in G531,32. 
In addition, the different titration behavior of the Xyl4 and Xyl2 peaks of G5 
(Supplementary Fig. 5) suggests that GlcA5-Xyl4 interacts more strongly than GlcA3-Xyl2 
with the Ca2+ site. Taken together, the NMR results demonstrate a high-affinity interaction 
and confirm the conclusion from the crystal structures that a single GlcA-Xyl repeat of 
matriglycan is sufficient for Ca2+-dependent binding to laminin α2 LG4-5. 
 
α-DG binding by other LG domains 
Ca2+-dependent α-DG binding is a function of many LG domain-containing proteins10-12,33. 
Structural comparison predicts that all these LG domains bind GlcA-Xyl repeats similarly to 
laminin α2 LG4, despite their divergent sequences (Fig. 5). The key determinants appear to 
be the Ca2+ ion and the conserved backbone structure around the ion, which strictly requires a 
glycine at the tip of one of the loops (Gly2826 in laminin α2). Mutation of this conserved 
glycine in neurexin LG2 or LG6 abolishes α-DG binding, as do mutations in the adjacent 
loop corresponding to laminin α2 residues 2872-2876 (ref. 41). Lysine and arginine residues 
in laminin α1 and α2 LG4-5 have been implicated in α-DG binding25,34. These basic residues 
are not conserved in other LG domains and likely interact non-specifically with the 
polyanionic carbohydrates on α-DG. Although some LG domains with an intact Ca2+ site 
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(e.g. LG5 of laminins α1 and α2) have been reported not to bind α-DG29, it is possible that 
the solid-phase assays used in these experiments were unable to detect interactions of lower 
affinity with matriglycan. 
 
 
DISCUSSION 
 
This study defines the structural basis of LG domain binding to matriglycan, the LARGE-
synthesized polysaccharides on dystroglycan. Our exoglycosidase digestion experiments 
demonstrate that [-GlcA-β1,3-Xyl-α1,3-] repeats are present on native α-DG from skeletal 
muscle, and that they are directly responsible for LG domain binding. Our structural results 
show that LG domains are Ca2+-dependent lectins that primarily recognize a single GlcA-
β1,3-Xyl repeat. The linkage-specific recognition of a disaccharide by a Ca2+ binding site 
represents a novel principle of carbohydrate recognition. In typical C-type lectins, such as 
mannose-binding protein, a Ca2+ ion binds the vicinal hydroxyl groups of one 
monosaccharide35. This binding mode is inherently of low (millimolar) affinity, and C-type 
lectins amplify their affinity for ligand either by extending the interaction surface beyond the 
Ca2+ site or by forming oligomeric assemblies35,36. The GlcA-Xyl repeats of the LARGE 
glycan achieve a remarkably high affinity for laminin α2 LG4-5 by acting as perfectly 
matched chelators of the LG4 Ca2+ site. Three features may contribute to reducing the 
entropic cost of binding: (1) no structural changes in the protein are required to accommodate 
the ligand; (2) the GlcA-Xyl disaccharide that chelates the Ca2+ ion is bound in a low-energy 
conformation that likely represents the solution state; and (3) two functional groups of the 
disaccharide replace Ca2+-bound water molecules in the ligand-free structure (Fig. 3a). The 
electrostatic interactions formed by the GlcA carboxylate group are not sufficient for tight 
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binding: the C form crystals were obtained in the presence of 120 mM GlcA, yet the electron 
density at the LG4 Ca2+ site does not indicate any bound GlcA. Thus, only GlcA that is β1,3-
linked to Xyl is bound with high affinity. 
 The presence of multiple GlcA-Xyl repeats in matriglycan is predicted to increase the 
apparent affinity for LG domains by favoring rapid rebinding after dissociation32. Notably, 
LG domains are often arranged in tandem. In agrin and perlecan, for instance, no single LG 
domain is sufficient for high-affinity α-DG binding, yet 2-3 LG domains together bind with 
apparent dissociation constants in the low nanomolar range29,37. The laminin α2 chain also 
has at least two α-DG binding sites28,29. The number of GlcA-Xyl repeats within a single 
matriglycan polysaccharide is unknown but likely to be large, given the ~60 kDa shift in 
electrophoretic mobility upon enzymatic digestion (Fig. 2) and the small number of sites 
modified by LARGE38,39. 100 GlcA-Xyl repeats (~30 kDa) would span ~150 nm and could 
potentially bind more than one molecule of laminin, agrin, or perlecan. The assembly of 
multiprotein complexes on a single matriglycan chain would explain the graded effect of 
LARGE-dependent glycosylation on the structure of the basement membrane and the 
effectiveness of muscle function20. 
 In conclusion, we have elucidated the atomic mechanism whereby laminin recognizes 
the unique post-translational modification of α-DG. The laminin-dystroglycan interaction was 
discovered over 20 years ago and has since been shown to be critically important for skeletal 
muscle function. The structural insights presented here will facilitate a deeper understanding 
of the mechanisms that underlie the dystroglycanopathies, as well as other physiological and 
pathological functions of dystroglycan. 
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Accession codes. Coordinates and structure factors have been deposited in the Protein Data 
Bank under accession codes 5IK4 (form C, apo), 5IK5 (form C, G6/7 complex), 5IK7 (form 
I, apo), 5IK8 (form I, G6/7 complex). 
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FIGURE LEGENDS 
 
Figure 1. Enzymatic digestion of oligosaccharide G5. (a) Schematic of the step-wise 
digestion of G5 with β-glucuronidase (Bgus) and α-xylosidase (Xylsa). MU, 4-methyl-
umbelliferone. (b) HPLC profile of G5 and its digestion products. Peaks a, b, c, and d 
indicate the products of each step of digestion. (c) MS spectrum of G5 (molecular mass: 968). 
(d) MS spectrum of peak a, indicating that the product of the first step is G4 (molecular mass: 
792). (e) MS spectrum of peak b, indicating that the product of the second step is G3 
(molecular mass: 660). (f) MS spectrum of peak c, indicating that the product of the third step 
is G2 (molecular mass: 484). (g) MS spectrum of peak d, indicating that the product of the 
fourth step is GlcA-MU (molecular mass: 352). The data shown are from a single 
experiment. This experiment was replicated three times using separately prepared samples. 
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Figure 2. Enzymatic digestion of skeletal muscle α-DG. (a) Rabbit skeletal muscle α-DG 
was treated with either β-glucuronidase (Bgus) or α-xylosidase (Xylsa), or both enzymes 
simultaneously.  The digestion product was analyzed by immunobloting with anti-α-DG 
glycan antibody IIH6 (DSHB, University of Iowa) and anti-α-DG core antibody (AF6868, 
R&D Systems). (b) Wild-type mouse skeletal muscle α-DG was treated with both Bgus and 
Xylsa, or no enzymes. The digestion product, and Largemyd mouse skeletal muscle α-DG, 
were analyzed by immunoblotting with anti-α-DG core antibody (AF6868, R&D Systems). 
(c) Wild-type mouse skeletal muscle α-DG was treated with both Bgus and Xylsa (or no 
enzymes) and analyzed by: immunoblotting with anti-α-DG core antibody; immunoblotting 
with anti-α-DG glycan antibodies IIH6 and VIA41 (DSHB, University of Iowa); and overlay 
assay with laminin-111 (Life Technologies)40. Immunoblotting with a rabbit polyclonal 
antibody against the α2 subunit of the DHPR Ca2+ channel (Campbell lab) was used for 
normalizing sample loading and as a marker for a control glycoprotein20. Bands labeled with 
asterisks that were detected by the polyclonal antibody against core α-DG are likely 
contaminants of the Xylsa preparation, as the same bands were observed in samples 
containing only the enzyme. This experiment was replicated three times using separately 
prepared samples. 
 
Figure 3. Crystal structure of laminin α2 LG4-5 bound to oligosaccharide G6/7. 
(a) Electron density for the G6/7 ligand in crystal form C. Shown is an unbiased (Fobs,lig – 
Fobs,apo), αcalc,apo difference electron density map (lig, G6/7 complex; apo, ligand-free 
structure) contoured at 2.0 σ superimposed onto the final model of G6/7 The sugars beyond 
Xyl4 are not defined by the electron density and are presumed to be disordered. The small 
green spheres indicate the positions of two water molecules in the native, ligand-free 
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structure. The MU group is situated on a crystallographic dyad, and the G6/7 ligand is bound 
with 50% occupancy to each of to the two symmetry-related binding sites. (b) Surface 
representation of laminin α2 LG4-5 (light blue, LG4; green, LG5, pink, Ca2+) with G6/7 
shown in atomic detail (yellow and red sticks). The arrow indicates the direction of the view 
used in panel c. (c) Atomic interactions between G6/7 (yellow carbon atoms) and laminin α2 
LG4 (light blue carbon atoms) in crystal form C. The ring carbon atoms of Xyl2 and GlcA3 
are numbered. Coordination bonds to the Ca2+ ion are indicated by solid lines. Two bridging 
water molecules are shown as small red spheres. Hydrogen bonds are indicated by dashed 
lines. 
 
Figure 4. NMR analysis of binding of oligosaccharide G5 to laminin α2 LG4-5. (a) The 
chemical structure of G5. (b) 1D 1H NMR spectra of the anomeric region of 3.0 µM G5 in the 
presence of 2.0 mM CaCl2 acquired in Tris-d11 buffer and various concentrations of laminin 
α2 LG4-5 as indicated. (c) 1D 1H NMR spectra of the anomeric region of 7.5 µM G5 
acquired in Tris-d11 buffer containing 10 mM EDTA and various concentrations of laminin 
α2 LG4-5 as indicated. The anomeric peaks in b and c are labeled. (d) Determination of 
dissociation constants based on the changes in intensity of the anomeric peak of Xyl4, which 
exhibits the greatest decrease upon addition of laminin α2 LG4-5 in the presence of Ca2+. The 
standard deviation from data fitting is reported. 
 
Figure 5. Structural comparison of α-DG-binding LG domains. (a-f) Molecular surfaces 
of LG domains with G6/7 positioned according to a local superposition of the protein 
backbones. Residues whose mutation abolishes α-DG binding25,34,41 are shown in green. 
(a) Laminin α2 LG4 (this study). (b) Laminin α1 LG4 (PDB entry 2JD4)34. (c) Agrin LG3 
(1PZ8)42. (d) Perlecan LG3 (3SH5)43. (e) α-Neurexin LG2 (2H0B)44. (f) α-Neurexin LG6 
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(3QCW)45. (g) Partial sequence alignment of the LG regions interacting with G6/7. Residues 
coordinating the Ca2+ ion are in magenta. 
 
  
20 
 
ONLINE METHODS 
 
Purification of α-DG from skeletal muscle. Rabbit α-DG was enriched from skeletal 
muscle (Pel-Freez Biologicals) using DEAE-cellulose and WGA-agarose columns as 
described46. α-DG was eluted from the WGA-agarose column using 50 mM Tris (pH 7.5), 
300 mM NaCl, 0.1% Triton X-100, 300mM GlcNAc, and heated to 99°C for 10 min in the 
presence of 10 mM 2-mercaptoethanol. The sample was buffer-exchanged using a PD-10 
column equilibrated with 150 mM sodium acetate (pH 5.5) and stored at –80°C. Mouse α-DG 
was enriched from wild-type and Largemyd skeletal muscle using a WGA-agarose column as 
described47. Samples were heated to 99°C for 10 min in the presence of 10 mM 
2-mercaptoethanol and buffer-exchanged into 150 mM sodium acetate (pH 5.0) using 
Amicon Ultra 0.5 ml centrifugal filters with a 10 kDa molecular weight cut-off. 
 
Synthesis of extended Xyl-GlcA-β-MU products (G3, G5, G6/7). LARGEdTM was 
purified using TALON metal affinity resin (Clontech) as described19. To generate Xyl-GlcA-
MU (G2), LARGEdTM attached to TALON beads was added to 5 mM UDP-xylose 
(CarboSource Services) and 5 mM glucuronic acid-β-MU (Sigma) in 100 mM sodium acetate 
(pH 5.5) containing 10 mM MgCl2 and 10 mM MnCl2 in a total volume of 0.5 ml. The 
solution was incubated for 4-5 days at 37°C with rotation. The reaction product was purified 
using reverse-phase HPLC on a Beckman Gold system (SUPELCOSIL LC-18 column, 25 cm 
x 4.6 mm, 5 micron) with HPLC buffer A (50 mM ammonium formate, pH 4.0) and HPLC 
buffer B (80% acetonitrile in buffer A). Using a 10% buffer B isocratic gradient and a flow 
rate of 1 ml/min, the G2 product gave a fluorescence signal (325 nm excitation, 380 nm 
emission) at ~18 min. The collected peak fractions were lyophilized, dissolved in ultra-pure 
water, and quantitated using fluorescence and GlcA-MU as a standard. GlcA-Xyl-GlcA-MU 
21 
 
(G3) was then produced from the G2 sample (1-2 mM in 0.5 ml of water) in a reaction with 
fresh LARGEdTM beads and 5 mM UDP-GlcA (Sigma), in 100 mM MES (pH 6.0) 
containing 10 mM MgCl2 and 10 mM MnCl2. This solution was incubated overnight at 37°C 
with rotation, and the reaction product purified using reverse-phase HPLC as described 
above. The procedure was repeated twice to generate G5, using fresh LARGEdTM beads at 
each step. For the synthesis of G6, the same beads were used for multiple steps and ES-MS 
and NMR analysis of the purified reaction product later revealed a ~50/50 mixture of G6 and 
G7. This sample, termed G6/7, was used in the crystallographic experiments. 
 
Synthesis of GlcA-Xyl-α-MU (X2). LARGEdTM attached to TALON beads was added to 
20 mM UDP-glucuronic acid and 10 mM xylose-α-MU (Carbosynth Limited, HPLC-purified 
before use) in 100 mM MOPS (pH 6.0) containing 10 mM MgCl2 and 10 mM MnCl2 in a 
total volume of 0.5 ml. The mixture was incubated at 37°C for 20 days with shaking at 1200 
rpm. The reaction product was purified using reverse-phase HPLC as described above. The 
collected peak samples were lyophilized, dissolved in water, and analyzed by ESI-MS. 
 
Digestion of G5 with exoglycosidases. T. maritima β-glucuronidase26 (Bgus) bearing a His-
tag was overexpressed in E. coli, and purified using TALON metal affinity resin. 
S. solfataricus α-xylosidase (Xylsa) was purified as described27 with some modifications. 
Briefly, the cell pellet was resuspended in 20 mM sodium phosphate buffer (pH 7.3), 150 
mM NaCl, 1% (v/v) Triton X-100, and homogenized by French press. After centrifugation 
(30 min at 40,000 x g), the crude extract was incubated with Benzonase (Novagen) for 1 h at 
room temperature and then heat-fractionated for 30 min at 55, 65, and 75°C. The supernatant 
was dialyzed against sodium phosphate buffer (25 mM, pH 7.5) and applied to a HiLoad 
16/10 Q-sepharose column (GE Healthcare). The enzyme was eluted at 750 mM NaCl by 
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using a linear gradient up to 1 M NaCl with a flow rate of 3 ml/min. G5 (100 µM) was 
incubated with Bgus (0.2 U) and 150 mM sodium acetate (pH 5.5), in a total volume of 200 
µl, for 3 hours at 65°C. The reaction mixture was centrifuged at 13000 g for 10 min, and the 
supernatant was analyzed using reverse-phase HPLC (solvent A was 50 mM ammonium 
formate pH 4.0, and solvent B was 80% acetonitrile in solvent A), and monitored by 
fluorescence detection (325 nm for excitation, and 380 nm for emission). The collected peak 
samples were lyophilized and dissolved in 50 µl of H2O. An aliquot of purified product was 
analyzed by ESI-MS, and the rest was used for the second step of digestion. The product of 
the first step of G5 digestion was incubated with Xylsa (0.2 U) and 150 mM sodium acetate 
(pH 5.5), in a total volume of 100 µl, for 3 hours at 65°C. The reaction mixture was analyzed 
using reverse-phase HPLC and ESI-MS as described above. The third and fourth digestion 
with Bgus and Xylsa, respectively, were carried out analogously in a total volume of 100 µl.  
 
Digestion of α-DG with exoglycosidases. Enriched rabbit α-DG (100 µl of the 150 mM 
sodium acetate (pH 5.5) solution) was mixed with Bgus (0.45 U) and/or Xylsa (0.09 U), or no 
enzymes, and incubated overnight at 65°C. Samples were then run on SDS-PAGE, 
transferred to PVDF-FL (Millipore), and probed with anti-α-DG core antibody (AF6868) and 
anti-α-DG glycan antibody (IIH6). Enriched rabbit α-DG (100 µl of the 150 mM sodium 
acetate (pH 5.5) solution) was mixed with Bgus (0.45 U) and/or Xylsa (0.09 U), or no 
enzymes, and incubated overnight at 65°C. Samples were then run on SDS-PAGE, 
transferred to PVDF-FL (Millipore), and probed with anti-α-DG core antibody (AF6868), 
rabbit polyclonal antibody against the α2 subunit of the DHPR Ca2+ channel41 (Campbell lab) 
and anti-α-DG glycan antibodies (IIH6, VIA41). The laminin overlay assay was performed as 
described40. 
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Solid-phase binding assay. GlcA-MU biotinylated at C3 of the MU group (custom synthesis 
by Sussex Research Laboratories, Ottawa, Canada) was incubated with LARGEdTM, 10 mM 
UDP- GlcA, 10 mM UDP- Xyl, 10 mM MgCl2 and 10 mM MnCl2 in 100 mM MES buffer 
(pH 6.5) at 37°C for 18 h. The enzymatic reaction was terminated by boiling in the presence 
of 50 mM EDTA. After centrifugation (20,000g for 10 min), the supernatant was fractionated 
using gel-filtration chromatography (Superdex peptide 10/300GL, GE Healthcare). The 
fractions corresponding to LARGE product of 10-200 kDa molecular mass were pooled. A 
streptavidin ELISA plate (Thermo Fisher) was coated with 10 µg of biotinylated hyaluronic 
acid, MW 200 kDa (Creative PEGWorks) and biotinylated (GlcA-Xyl)n-GlcA-MU overnight 
at 4°C. All subsequent incubations were performed at room temperature. The coated plate 
was washed with laminin binding buffer LBB (746 mM triethanolamine, 140 mM NaCl, 1 
mM CaCl2, 1 mM MgCl2, pH 7.6) and blocked with 3% bovine serum albumin (BSA) in LBB 
for 2 h. A series of laminin-111 (Life Technologies) dilutions was prepared from 0 to 10 nM 
in 1% BSA, 2 mM CaCl2 and added to the plate for one hour. Wells were washed with 1% 
BSA-LBB and incubated for 1 h with anti-laminin antibody (Sigma L9393) diluted 1:10,000 
in 3% BSA-LBB. The plate was washed three times with 1% BSA-LBB before adding anti-
rabbit IgG-HRP in 3% BSA-LBB for 30 minutes. After washing as before, the plate was 
developed with o-phenylenediamine dihydrochloride and H2O2, reactions were stopped with 
2 N H2SO4, and absorbance at 490 nm was measured using a microplate reader. 
 
Protein production for crystallography. DNA encoding residues 2730-3118 of the mouse 
laminin α2 chain (UniProt Q60675) was amplified and ligated into pCEP-Pu48. Human 
embryonic kidney HEK293 c18 cells (American Type Culture Collection) were used for 
protein production as described49. The combined conditioned media from 1 HYPERFlask 
(Corning) were concentrated and buffer-exchanged into 50 mM HEPES (pH 7.5), 2 mM 
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CaCl2 using a VivaFlow 200 cross-filtration device (Sartorius Stedim Biotech) with a 30 kDa 
molecular weight cut-off. The laminin α2 LG4-5 protein was purified using heparin affinity 
chromatography on an Äkta Purifier (GE Healthcare) and eluted at ~240 mM NaCl. The 
protein was then concentrated to 5 mg/ml, flash-frozen in liquid nitrogen, and stored at -80℃ 
for future use. Upon thawing, the protein was further purified using size exclusion 
chromatography on a Superdex 200 Increase column (GE Healthcare) running in 20 mM 
HEPES (pH 7.5), 130 mM NaCl, 2 mM CaCl2. This material was used for all biochemical 
experiments and for the production of crystal form C. To obtain crystal form I, an amino-
terminally truncated construct spanning residues 2742-3118 (α2 LG4-5 ΔN) was made and 
purified as described for the longer construct. 
 
Protein crystallization and ligand soaking. Crystals were grown by hanging drop vapor 
diffusion. For crystal form C, 2 µl of a 9 mg/ml solution of laminin α2 LG4-5 protein in 10 
mM HEPES (pH 7.5), 65 mM NaCl, 2 mM CaCl2 were mixed with an equal volume of 
precipitant solution composed of HEPES/MOPS (pH 7.5), 120 mM glucuronic acid and 30% 
of the polyethylene glycol 8000/glycerol mixture of the Morpheus screen (Molecular 
Dimensions). For crystal form I, 1 µl of a 7 mg/ml solution of α2 LG4-5 ΔN protein in 10 
mM HEPES (pH 7.5), 65 mM NaCl, 2 mM CaCl2 was mixed with an equal volume of 100 
mM dibasic ammonium citrate (pH 5.3), 18% polyethylene glycol 3350. Crystals of both 
forms appeared within two days. A 1 mM solution of G6/7 in precipitant solution was added 
to the crystallization drops in small quantities over the course of days (typically 0.2 µl/day) 
until the desired concentration was reached (250 and 850 µM for crystal forms C and I, 
respectively). Form C crystals did not require further cyroprotection before flash-freezing in 
liquid nitrogen. Form I crystals were briefly soaked in mother liquor supplemented with 20% 
ethylene glycol before freezing. 
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X-ray data collection and processing. Diffraction data were collected at beamlines I02 (λ = 
0.979 Å; form C, apo; form C, G6/7; form I, G6/7) and I04-1 (λ = 0.920 Å; form I, apo) of 
the Diamond Light Source (Oxfordshire, UK) and processed using the xia2 pipeline50. The 
resolution limits were determined using the CC1/2 ≥ 0.5 criterion51. Phases were obtained by 
molecular replacement using Phaser52 with the laminin α2 LG4-5 structure53 as a search 
model. Manual rebuilding and refinement were done using Coot54 and PHENIX55. Target 
values for the glycosidic bond stereochemistry were derived from high-resolution structures 
of protein-glycosaminoglycan complexes in the Protein Data Bank and from polysaccharide 
structures in the Cambridge Structural Database (C-O bonds 1.41 ± 0.05Å, C-O-C angles 
114.8 ± 2.5º). In form C crystals the MU group of the G6/7 ligand is located on a 
crystallographic dyad, resulting in statistical disorder between the two symmetry-related 
orientations (Supplementary Fig. 3). The refinement protocol assumed a 50/50 mixture of 
ligand-bound and free sites. Two Ca2+-bound water molecules from the ligand-free structure 
were included with occupancies of 0.5. Refinement of the G6/7 ligand with an occupancy of 
0.5 resulted in in an average B-factor of 42.3 Å2 for Xyl4-GlcA3-Xyl2-GlcA1, compared 
with 37.1 Å2 for the Ca2+ ion. In form I crystals, the G6/7 ligand bound to LG4 of molecule B 
was refined with full occupancy. Data collection and refinement statistics are summarized in 
Supplementary Table 1. The final crystallographic models have excellent Ramachandran 
statistics (>95% favored; 0% outliers in form C crystals; 0.13% outliers in form I crystals)56. 
 
NMR spectroscopy. 1D 1H NMR spectra of the oligosaccharide samples in the absence and 
presence of laminin α2 LG4-5 protein were acquired on a Bruker Avance II 800 MHz 
spectrometer equipped with a cryoprobe at 25°C using a 50 ms T1ρ filter consisting of a train 
of spin-lock pulses to eliminate the broad resonances from the protein57. The laminin α2 
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LG4-5 titrations in the presence of Ca2+ were performed in 25 mM Tris-d11 (pH 7.5), 50 mM 
NaCl, and 2 mM CaCl2 in 100% D2O. The titrations in the absence of of Ca2+ were 
performed in 25 mM Tris-d11 (pH 7.5), 50 mM NaCl, and 10 mM EDTA in 100% D2O. The 
13C and 1H resonances of oligosaccharides G5 and G3 were reported previously19. The 13C 
and 1H resonances of disaccharide X2 were assigned in this study using 1H homonuclear two-
dimensional DQF-COSY, TOCSY, and ROESY experiments, as well as 1H/13C heteronuclear 
two-dimensional HMQC and H2BC experiments58. The 1H chemical shifts are referenced to 
2,2-dimethyl-2-silapentane-5-sulfonate. The NMR spectra were processed using NMRPipe59 
and analyzed using NMRView60. For the resolved anomeric oligosaccharide peaks, the bound 
fraction was calculated by measuring the difference in the peak intensity in the absence (free 
form) and presence (bound form) of laminin α2 LG4-5, and then dividing by the peak 
intensity of the free form. To obtain dissociation constants, the data were fitted to the 
standard quadratic equation using GraphPad Prism (GraphPad Software).  
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Supplementary Results 
 
Supplementary Table 1. Crystallographic statistics of laminin α2 LG4-5 structures without 
ligand (apo) and with bound G6/7 oligosaccharide. 
 
 Form C, apo Form C, G6/7 Form I, apo Form I, G6/7 
Data collection     
Space group C2221 C2221 I212121 I212121 
Cell dimensions 
     a, b, c (Å) 
     α, β, γ (°) 
 
70.69, 111.4, 124.5 
90, 90, 90 
 
70.39, 110.7, 123.9 
90, 90, 90 
 
112.1, 129.1, 147.1 
90, 90, 90 
 
111.5, 126.3, 144.0 
90, 90, 90 
Resolution (Å) 50.8–1.27  
(1.32–1.27)a 
53.6–1.39  
(1.44–1.39) 
89.1–2.00  
(2.07–2.00) 
51.3–2.00  
(2.07–2.00) 
CC1/2 0.999 (0.572) 0.999 (0.495) 0.997 (0.640) 0.999 (0.618) 
Rmerge  0.051 (1.89) 0.035 (0.422) 0.133 (4.26) 0.088 (1.64) 
I/σ(I) 19.3 (1.3) 17.3 (1.3) 12.9 (1.5) 17.3 (1.7) 
Completeness (%) 99.8 (99.7) 83.7 (35.8)b 95.0 (95.7) 100 (99.9) 
Redundancy 12.9 (11.8) 3.9 (1.6)b 11.9 (12.1) 13.5 (13.6) 
 
Refinement     
Resolution (Å) 1.27 1.39 2.00 2.00 
No. reflections 128754 81183 68371 68770 
Rwork/ Rfree 0.155/0.179 0.150/0.177 0.189/0.219 0.177/0.210 
No. atoms 
     Protein 
     G6/7 glycan 
     Ca2+ 
     Water + buffer molecules 
 
5959 
 
2 
507 
 
5998 
97 
2 
539 
 
11635 
 
4 
506 
 
11479 
92 
4 
694 
B-factors (Å2) 
     Protein 
     G6/7 glycan 
     Ca2+ 
     Water, buffer molecules 
 
32.1 
 
26.9 
43.8 
 
28.6 
50.6 
25.3 
43.2 
 
60.8 
 
86.7 
62.2 
 
54.7 
107.7 
62.9 
64.1 
R.m.s. deviations 
     Bond lengths (Å) 
     Bond angles (°) 
 
0.013 
1.3 
 
0.007 
1.4 
 
0.003 
0.67 
 
0.003 
0.74 
aEach data set was collected from a single crystal. The highest-resolution shell is shown in parantheses. 
bThis data set is 99.5% complete to 1.69 Å resolution, with >4 redundancy in all resolution shells. Inclusion of 
the incomplete data from the 1.69–1.39 Å range improved both the refinement R-factors and the detail in the 
electron density map. 
  
Supplementary Table 2. Torsion angles of the glycosidic linkages in G6/7. For 1-3 
glycosidic linkages, the torsion angles are defined as follows: φ = O5’-C1’-OX’-C3 and 
ψ = C1’-OX’-C3-C2 (the primed atoms are from the sugar at the non-reducing end). 
 
 Form C crystals Form I crystals Energy minimuma  
Xyl4-α1,3-GlcA3 φ = 113° 
ψ = 252° 
φ = 79° 
ψ = 240° 
φ ≈ 70° 
ψ ≈ 205–275° 
 
GlcA3-β1,3-Xyl2 φ = 285° 
ψ = 249° 
φ = 267° 
ψ = 274° 
φ ≈ 295° 
ψ ≈ 220–290° 
 
Xyl2-α1,3-GlcA1 φ = 72° 
ψ = 234° 
φ = 69° 
ψ = 192° 
φ ≈ 70° 
ψ ≈ 205–275° 
aEstimated from the energy functions in ref. 1. 
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